Skip To Main Content
Hailey Turner-Hubbard on Muck Rack

Hailey Turner-Hubbard

As seen in: Nature, PLOS
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hailey

Contact Hailey, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape

|
By Fan Bu, Divyasha Saxena, Hailey Turner-Hubbard, PLOS Pathogens
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: Bu F, Saxena D, Turner-Hubbard H, Delaney A, Batra L, Fricke C, et al. (2026) Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape. PLoS Pathog 22(5): e1014223.
Open in Who Shared Issue with article?

Structures of Marburgvirus glycoprotein and its complex with NPC1 receptor

|
By Fan Bu, Hailey Turner-Hubbard, Lanying Du, Ge Yang, Bin Liu, Fang Li, Morgan Herbst
| Nature Verified
Abstract Marburgviruses (MBVs) cause severe haemorrhagic fever with higher fatality rates than Ebola virus (EBOV)1,2,3,4. Here we show that the MBV glycoprotein (GP) mediates viral entry more efficiently than EBOV GP. Using cryo-EM, we determined structures of MBV GP in three states: (1) unbound; (2) bound to its endosomal receptor NPC1; and (3) complexed with a neutralizing nanobody.
Open in Who Shared Issue with article?

A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections

|
By Fan Bu, Kimberly M. Morsheimer, Brett Eaton, Hailey Turner-Hubbard, PLOS Pathogens
| PLOS
Loading metrics Open Access Peer-reviewed Research Article ? This is an uncorrected proof. Citation: Bu F, Ye G, Morsheimer K, Turner-Hubbard H, Eaton B, Anantpadma M, et al. (2026) A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections. PLoS Pathog 22(1): e1013878.
Open in Who Shared Issue with article?
See all 3 articles